The global Microcrystalline Cellulose (MCC) market was valued at approximately USD 1.3 billion in 2025 and is expected to grow significantly during the forecast period.
Pharmaceutical demand remains robust, while observing the fastest growth in food and personal care.
DuPont (formerly FMC), DFE Pharma, Asahi Kasei, JRS Pharma, and Roquette collectively account for approximately 45- 55% of the global MCC Market.
The MCC market faces challenges including raw material fluctuations, supply chain disruptions, pricing pressures, changing regulations, and competition from alternative excipients.
Asia Pacific holds the largest share of the global Microcrystalline Cellulose (MCC) market, driven by the strong presence of pharmaceutical, food, and personal care manufacturing industries.